-

Owens & Minor Names Jonathan Leon Executive Vice President, Chief Financial Officer

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), announced today that Mr. Jonathan Leon has been named Executive Vice President, Chief Financial Officer, effective immediately. Leon will maintain his corporate treasurer responsibilities while a search for his successor is underway. Mr. Leon has been with the Company since 2017, most recently serving as Interim Chief Financial Officer and Corporate Treasurer since June 2024. He will report directly to Mr. Edward Pesicka, President and Chief Executive Officer of Owens & Minor.

Mr. Leon brings more than 25 years of corporate finance, treasury and strategy experience to the role. Previously, he served as Senior Vice President and Corporate Treasurer at the Company, leading its financial operations since 2017. He was also involved in the Company’s investor relations, corporate finance, mergers and acquisitions, and corporate development efforts.

“After a comprehensive process, the Board and I unanimously agreed that Jon is the ideal candidate to serve as Owens & Minor’s next Chief Financial Officer. His extensive knowledge of the healthcare sector, financial acumen, established relationships with investors, and proven leadership capabilities will be invaluable as we continue our progress toward achieving our long-term goals outlined at our recent Investor Day,” said Mr. Pesicka.

Before joining Owens & Minor, Mr. Leon spent 18 years at The Brink’s Company, where he served as Treasurer and in several related investor relations and corporate finance roles. Mr. Leon earned a B.S. in Finance from the University of Connecticut.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™. For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.

OMI-CORP

OMI-IR

Contacts

Investors
Alpha IR Group
Jackie Marcus or Nick Teves
OMI@alpha-ir.com

Media
Stacy Law
media@owens-minor.com

Owens & Minor

NYSE:OMI

Release Versions

Contacts

Investors
Alpha IR Group
Jackie Marcus or Nick Teves
OMI@alpha-ir.com

Media
Stacy Law
media@owens-minor.com

More News From Owens & Minor

Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (“the Company”) today announced that it will change its name to Accendra Health, Inc. with an anticipated effective date of December 31, 2025. The name change affects only the name of the parent corporation and is intended to better reflect the Company’s strategic direction and future organizational focus as a leader in the home-based care market. The Company will continue to use and operate under the Apria and Byram Healthcare...

Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2025 Global Healthcare Conference On Tuesday, December 2, 2025, Ed Pesicka, the Company’s President and Chief Executive Officer, and Will Parrish, the Company’s Vice President of Strategy, Corporate Development, & Investor Relations, are scheduled to participate in a fireside chat at 2:30 P.M. ET and h...

Owens & Minor Reports Third Quarter 2025 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “Our recent announcement on the sale of our Products & Healthcare Services segment is another meaningful step in our strategy to pivot our focus to th...
Back to Newsroom